LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 1209 | 3953 | 4012 | 0.9866 | 0.9852 |
MCF7 | Sorafenib | 10 | uM | LJP6 | 72 | hr | 1209 | 2138 | 4012 | 0.5330 | 0.3897 |
MCF7 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 3886 | 4012 | 0.9700 | 0.9661 |
MCF7 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3825 | 4012 | 0.9544 | 0.9474 |
MCF7 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3843 | 4012 | 0.9590 | 0.9528 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1716 | 4012 | 0.4263 | 0.2189 |
MCF7 | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 653 | 4012 | 0.1621 | -0.3030 |
MCF7 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 604 | 4012 | 0.1507 | -0.3309 |
MCF7 | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 591 | 4012 | 0.1472 | -0.3407 |
MCF7 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 502 | 4012 | 0.1251 | -0.3993 |
MCF7 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1209 | 443 | 4012 | 0.1106 | -0.4408 |
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1961 | 4012 | 0.4890 | 0.3221 |
MCF7 | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1692 | 4012 | 0.4224 | 0.2147 |
MCF7 | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1453 | 4012 | 0.3622 | 0.1113 |
MCF7 | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 1184 | 4012 | 0.2951 | -0.0132 |
MCF7 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 993 | 4012 | 0.2477 | -0.1080 |
MCF7 | AZD7762 | 10 | uM | LJP6 | 72 | hr | 1209 | 617 | 4012 | 0.1545 | -0.3225 |
MCF7 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1199 | 4012 | 0.2986 | -0.0063 |
MCF7 | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1108 | 4012 | 0.2765 | -0.0494 |
MCF7 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1030 | 4012 | 0.2570 | -0.0888 |
MCF7 | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 1024 | 4012 | 0.2558 | -0.0924 |
MCF7 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 985 | 4012 | 0.2457 | -0.1122 |
MCF7 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1209 | 388 | 4012 | 0.0968 | -0.4820 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3745 | 4012 | 0.9334 | 0.9219 |
MCF7 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 673 | 4012 | 0.1682 | -0.2872 |